Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns Medical and healthcare-related publications and documentation.
    Difference
    24%
    Check dated 2024-05-22T07:58:45.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    15 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change represents an update in the estimated completion date for the study regarding the evaluation of the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma.
    Difference
    0.0%
    Check dated 2024-05-09T02:15:11.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The recent change on the webpage indicates an update in the recruitment status and contact information for various medical centers participating in a clinical trial for selinexor as a maintenance treatment for patients with p53 wild-type endometrial carcinoma. The change reflects new locations, contact persons, and principal investigators involved in the study, suggesting progress in the trial enrollment and expansion of research sites.
    Difference
    3%
    Check dated 2024-05-07T20:05:43.000Z thumbnail image
  8. Check
    23 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T22:36:02.000Z thumbnail image

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.